AJANTPHARM2020-07-012020-09-30in-bse-fin:OneOperatingExpenses01Member AJANTPHARM2020-07-012020-09-30in-bse-fin:FourOperatingExpenses01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares AJANTPHARM 2020-04-01 2021-03-31 2020-10-23 INR Crores Half yearly true Cash Flow Indirect Single segment PHARMACEUTICAL 2020-07-01 2020-09-30 Unaudited Consolidated 7159100000.00 48500000.00 7207600000.00 1886300000.00 249700000.00 -582400000.00 1305300000.00 15300000.00 283300000.00 1557700000.00 4715200000.00 2492400000.00 0.00 2492400000.00 825900000.00 -35700000.00 790200000.00 0.00 1702200000.00 0.00 0.00 0.00 0.00 1702200000.00 -44200000.00 1658000000.00 1658000000.00 0.00 175400000.00 2 19.51 19.50 0.00 0.00 19.51 19.50 1. The above results have been reviewed by Audit Committee and approved by the Board of Directors at their meeting held on 3 November 2020. n2. Statutory Auditors have expressed an unqualified review opinion for quarter and half year ended 30 September 2020. n3. Board of Directors have approved payment of interim dividend on 3 November 2020 of Rs. 9.50 per equity share of face value of Rs. 2 each. n4. Board of Directors have approved buyback proposal on 3 November 2020, for purchase by the Company of up to 7,35,000 shares of Rs. 2 each (representing 0.84% of total paid-up equity capital) from the shareholders of the Company on a proportionate basis by way of a tender offer at a price of Rs.1,850 per equity share for an aggregate amount not exceeding Rs. 135.98 crores in accordance with the provisions of the Companies Act, 2013 and the SEBI (Buy Back of Securities) Regulations, 2018. n5. The consolidated unaudited financial results of the Company, its wholly owned subsidiaries and step-down subsidiary (“the Group”) have been prepared as per Ind AS 110 on Consolidated Financial Statements. There is no minority interest. n6. The Group has taken into account the possible impacts of COVID-19 in preparation of the financial statements, including but not limited to its assessment of liquidity and going concern assumption, recoverable values of its financial and non-financial assets, impact on revenues and on costs. The Group has been able to effectively manage the operations till now with appropriate safety precautions, without any significant impact of COVID-19 on the business. The actual impact of COVID-19 in coming quarters may be different from that of earlier quarters, depending on how the situation evolves globally. The Group will continue to closely monitor future economic conditions to ensure business continuity. n7. During the quarter Nil equity shares (previous year 6,500) of Rs. 2 each, fully paid up, were allotted upon exercise of vested options pursuant to the Employees Stock Options Scheme, 2011, resulting in an increase in the paid-up share capital by ` Nil (previous year Rs. 13,000) and securities premium account by Rs. Nil (previous year Rs. 0.81 crores). n8. Exceptional item in the quarter ended 30 September 2019 and year ended 31 March 2020 represents loss due to a fire and other events at Guwahati plant net of minimum insurance claim receivable. The claim has been settled and there is no further loss on this account. Single segment 2020-04-01 2020-09-30 Unaudited Consolidated 13841100000.00 179700000.00 14020800000.00 3425000000.00 426200000.00 -766600000.00 2663200000.00 31600000.00 563500000.00 3118600000.00 9461500000.00 4559300000.00 0.00 4559300000.00 1357200000.00 22300000.00 1379500000.00 0.00 3179800000.00 0.00 0.00 0.00 0.00 3179800000.00 -36400000.00 3143400000.00 3143400000.00 0.00 175400000.00 2 36.44 36.44 0.00 0.00 36.44 36.44 Other Expenses 1557700000.00 Other Expenses 3118600000.00 31600000.00 -1376300000.00 168800000.00 0.00 -267500000.00 100000.00 -33000000.00 121900000.00 0.00 198600000.00 0.00 70600000.00 0.00 563500000.00 79000000.00 -14500000.00 -7400000.00 247900000.00 6400000.00 -50300000.00 0.00 0.00 2500000.00 -110600000.00 0.00 0.00 0.00 0.00 0.00 -368700000.00 4190600000.00 0.00 0.00 -7400000.00 1050600000.00 0.00 3132600000.00 0.00 0.00 1608600000.00 3531600000.00 0.00 0.00 0.00 0.00 0.00 702600000.00 14700000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7400000.00 0.00 -143500000.00 0.00 -2747000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 435700000.00 86200000.00 0.00 0.00 31600000.00 0.00 0.00 -553500000.00 -167900000.00 0.00 -167900000.00 2023500000.00 1855600000.00